Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the effects of taking repeated doses of AZD6280 on
the blood levels of midazolam and caffeine in healthy volunteers